Epidemiology of insulin resistance and its relation to coronary artery disease

American Journal of Cardiology

Volumn 84, Issue 1 A, 1999, Pages 11-14

  Haffner, Steven M ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; TRIACYLGLYCEROL;

BLOOD PRESSURE MONITORING; CALCULATION; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; CORONARY ARTERY DISEASE; DISEASE SEVERITY; FACTORIAL ANALYSIS; FOLLOW UP; GLUCOSE TOLERANCE; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; POSTPRANDIAL STATE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

EID: 0033536224     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00351-3     Document Type: Conference Paper

References (28)

1. Zavaroni I., Bonora E., Pagliara M., Dall Aglio E.D., Luchetti L., Buonanno G., Bonati P.A., Bergonzani M., Gnudi L., Passeri M., Reaven G. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med. 320:1989;702-706.
2. Haffner S.M., Valdez R.A., Hazuda H.P., Mitchell B.D., Morales P.A., Stern M.P. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes. 41:1992;715-722.
3. Meigs J.B., D'Agostino R.B. Sr, Wilson P.W.F., Cupples L.A., Nathan D.M., Singer D.E. Risk variable clustering in the insulin resistance syndrome the Framingham Offspring Study . Diabetes. 46:1997;1594-1600.
4. Reaven G.M. Role of insulin resistance in human disease. Diabetes. 37:1988;1595-1607.
5. Reaven G.M., Chen Y.-D.I., Jeppesen J., Maheux P., Krauss R.M. Insulin resistance and hyperinsulinemia in individuals with small, dense, low density lipoprotein particles. J Clin Invest. 92:1993;141-146.
6. Reaven G.M. Role of insulin resistance in human disease (syndrome X) an expanded definition . Annu Rev Med. 44:1993;121-131.
7. Jeppesen J., Hollenbeck C.B., Zhou M.-Y., Coulston A.M., Jones C., Chen Y.-D.I., Reaven G.M. Relation between insulin resistance, hyperinsulinemia, postheparin plasma lipoprotein lipase activity, and postprandial lipemia. Arterioscler Thromb Vasc Biol. 15:1995;320-324.
8. Ruige J.B., Assendelft W.J.J., Dekker J.M., Kostense P.J., Heine R.J., Bouter L.M. Insulin and risk of cardiovascular disease a meta-analysis . Circulation. 97:1998;996-1001.
9. Welin L., Eriksson H., Larsson B., Ohlson L.-O., Svärdsudd K., Tibblin G. Hyperinsulinaemia is not a major coronary risk factor in elderly men the Study of Men Born in 1913 . Diabetologia. 35:1992;766-770.
10. Ferrara A., Barrett-Connor E.L., Edelstein S.L. Hyperinsulinemia does not increase the risk of fatal cardiovascular disease in elderly men or women without diabetes the Rancho Bernardo Study, 1984-1991 . Am J Epidemiol. 140:1994;857-869.
11. Orchard T.J., Eichner J., Kuller L.H., Becker D.J., McCallum L.M., Grandits G.A. Insulin as a predictor of coronary heart disease interaction with apolipoprotein E phenotype: a report from the Multiple Risk Factor Intervention Trial . Ann Epidemiol. 4:1994;40-45.
12. Eschwege E., Richard J.L., Thibult N., Ducimetière P., Warnet J.M., Claude J.R., Rosselin G.E. Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels the Paris Prospective Study, ten years later . Horm Metab Res Suppl. 15:1985;41-46.
13. Pyörälä K., Savolainen E., Kaukola S., Haapakoski J. Plasma insulin as coronary heart disease risk factor relationship to other risk factors and predictive value during 9 1 2 -year follow-up of the Helsinki Policemen Study population . Acta Med Scand. 701:(suppl):1985;38-52.
14. Pyörälä M., Miettinen H., Laakso M., Pyörälä K. Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men the 22-year follow-up results of the Helsinki Policemen study . Circulation. 98:1998;398-404.
15. Després J.-P., Lamarche B., Mauriège P., Cantin B., Dagenais G.R., Moorjani S., Lupien P.-J. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 334:1996;952-957.
16. Lamarche B., Tchernof A., Moorjani S., Cantin B., Dagenais G.R., Lupien P.J., Després J.-P. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men prospective results from the Québec Cardiovascular Study . Circulation. 95:1997;69-75.
17. Lamarche B., Tchernof A., Mauriège P., Cantin B., Dagenais G.R., Lupien P.J., Després J.-P. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA. 279:1998;1955-1961.
18. Howard G., O'Leary D.H., Zaccaro D., Haffner S., Rewers M., Hamman R., Selby J.V., Saad M.F., Savage P., Bergman R. Insulin sensitivity and atherosclerosis. Circulation. 93:1996;1809-1817.
19. Haffner S.M., Lehto S., Rönnemaa T., Pyörälä K., Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 339:1998;229-234.
20. Diabetes 1996 Vital Statistics. 1996;29 American Diabetes Association, Chicago.
21. Kannel W.B., McGee D.L. Diabetes and cardiovascular disease the Framingham Study . JAMA. 241:1979;2035-2038.
22. Haffner S.M., Miettinen H. Insulin resistance implications for type II diabetes mellitus and coronary heart disease. Am J Med. 103:1997;152-162.
23. Charles M.A., Fontbonne A., Thibult N., Warnet J.-M., Rosselin G.E., Eschwege E. Risk factors for NIDDM in white populations Paris Prospective Study . Diabetes. 40:1991;796-799.
24. Haffner S.M., Stern M.P., Mitchell B.D., Hazuda H.P., Patterson J.K. Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution. Diabetes. 39:1990;283-288.
25. Lillioja S., Mott D.M., Spraul M., Ferraro R., Foley J.E., Ravussin E., Knowler W.C., Bennett P.H., Bogardus C. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus prospective studies of Pima Indians . N Engl J Med. 329:1993;1988-1992.
26. Warram J.H., Martin B.C., Krolewski A.S., Soeldner J.S., Kahn C.R. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med. 113:1990;909-915.
27. Haffner S.M., Gonzalez C., Mykkänen L., Stern M. Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to NIDDM the Mexico City Diabetes Study . Diabetologia. 40:1997;830-837.
28. Welborn T.A., Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care. 2:1979;154-160.